St. Louis, United States
RiverVest Venture Partners® is a venture capital firm focused on identifying and shaping early-stage life science companies to create significant shareholder value. Because of its extensive operating expertise, RiverVest is able to help entrepreneurs achieve near-term objectives that position their companies for exit. Established in 2000, RiverVest has funded 34 innovative life science companies and has assets under management of $290 million. For more information, please visit
48
Total Investments
31
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Finance, Financial Services
Funding Stage
Series A +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About RiverVest
Recent Investments (48)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Aug 2025 | |
| Series C | •••••• | Apr 2025 | |
| Series C | •••••• | Apr 2025 | |
| Series C | •••••• | May 2024 | |
| Series B | •••••• | Mar 2024 | |
•••• ••••
|
Series C | •••••• | Sep 2023 |
|
•••• ••••
|
Grant | •••••• | May 2023 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Feb 2023 |
|
•••• ••••
|
Venture Round | •••••• | Jan 2023 |
|
•••• ••••
|
Series A | •••••• | Nov 2022 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
